Skip to content
Eye3 Logo

About us

Eye3 is developing a next-generation point of care screening device for detecting alcohol and recreational drugs.

In partnership with McMaster University, Eye3’s objective is to conduct performance and validation studies to support regulatory submissions and commercialization.

Program engagement

Leadership

Kate Riley

CEO

David Wilson

Founder

Sector

Subsector

i.d.e.a. Fund Applications Open

Applications are now open for i.d.e.a. Fund Cohort 4

Are you developing and/or redesigning new green products, services, processes, and technologies that reduce environmental impact?

The i.d.e.a.™ Fund program focuses on supporting a more sustainable economy while fostering an inclusive and equitable growth in southern Ontario. Find out if you’re eligible to access up to $20,000 in matching seed funding and 30 hours of expert mentorship.

Applications are open from June 16 to July 7, 2025.